Komori
Share Issuance and Disposal4571Nano Holdings,Inc.Pharmaceuticals

Notice Regarding the Monthly Exercise Status of the 22nd Stock Acquisition Rights (with Exercise Price Adjustment Provisions)

In July 2026, 2,600 of the 22nd Series of Stock Acquisition Rights were exercised, and 260,000 new shares were delivered. The number of unexercised stock acquisition rights stood at 265,650 at the end of the month.

Worth reading
55In focus
Scored from 2 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
260000
Shares
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Exercise status of stock acquisition rights with exercise price adjustment clauses

発行・処分する株式数260,000Shares

260,000 new shares

発行済株式総数

0.36% (exercise ratio subject to exercise restrictions)

The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.

Terms of the stock acquisition rights
Exercise price
¥94–¥97 (exercise price in July 2026; details of the adjustment clause not disclosed)
Number of Stock Acquisition Rights
The total number issued can be calculated from the statement that 2,600 rights represented 0.70% of the total issued, but the document does not disclose the total number itself. The number of unexercised rights was 268,250 at the beginning of the month and 265,650 at the end of the month.
Procedures under the Corporate Code of Conduct
Describes compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Matters.
Most recent equity financing
Timing 30 October 2025 / Type Issuance of the 22nd Series of Stock Acquisition Rights (with exercise price adjustment clause) / Amount Not disclosed
Details of issuance or disposal
ItemDetails
Type of issuance or disposalExercise status of stock acquisition rights with exercise price adjustment clauses
Number of shares to be issued or disposed of260,000 new shares
Dilution Rate0.36% (exercise ratio subject to exercise restrictions)
Total number of issued shares83,536,758 shares (as of the end of the month preceding the relevant month) → Not disclosed
Exercise price¥94–¥97 (exercise price in July 2026; details of the adjustment clause not disclosed)
Number of Stock Acquisition RightsThe total number issued can be calculated from the statement that 2,600 rights represented 0.70% of the total issued, but the document does not disclose the total number itself. The number of unexercised rights was 268,250 at the beginning of the month and 265,650 at the end of the month.
Procedures under the Corporate Code of ConductDescribes compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Matters.
Most recent equity financingTiming 30 October 2025 / Type Issuance of the 22nd Series of Stock Acquisition Rights (with exercise price adjustment clause) / Amount Not disclosed
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To report the monthly exercise status of the 22nd Series of Stock Acquisition Rights in July 2026.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Monthly Exercise Status of the 22nd Stock Acquisition Rights (with Exercise Price Adjustment Provisions) | Nano Holdings,Inc. (4571) timely disclosure | Komori